CSL Behring

SAB joins forces with Pennsylvania company to develop COVID-19 therapeutic

Sioux Falls-based SAB Biotherapeutics is joining with global biotherapeutics leader CSL Behring to rapidly develop SAB-185, a COVID-19 therapeutic candidate on track for clinical evaluation by early summer.

11 months ago

SAB Biotherapeutics to collaborate with global biotherapeutics leader

Sioux Falls-based SAB Biotherapeutics has entered into multiple collaboration and option agreements with Pennsylvania-based CSL Behring, a global biotherapeutics company that has more than 20,000 employees.

1 year ago

News Tip

Have a business news item to share with us?

Scroll to top